We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...
A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is ...
Can calcitonin and carcinoembryonic antigen doubling times predict progression of thyroid carcinoma?
This study enrolled consecutive patients with MTC who were treated at a single center in France between January 2005 and August 2006. Eligible patients had elevated calcitonin levels. At enrollment, ...
A simple and reproducible test is still needed to identify in newly diagnosed stage A CLL patients, those patients with a higher risk of progressive disease. Toward this end, we prospectively ...
PSA doubling time of 6 months or less and seminal vesicle invasion were significant predictors of biochemical recurrence. Salvage external beam radiation therapy (EBRT) is effective in some patients ...
Many patients with high-risk biochemically recurrent prostate cancer based on PSA doubling time are unidentified in clinical practice. Clinicians unaware of patients’ PSA doubling time (PSADT) at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results